The latest episode of the DDW &#x27;In Conversation With&#x27; series is available to listen to below.<br>This week, Bruno Quinney speaks to Suzanne Caruso, President of Strategic Intelligence and Clinical &amp; Regulatory at Norstella. Norstella supports drug developers looking to take their treatments from pipeline to patients, finding solutions to complexities in the drug development timeline. One of these solutions is AI.<br>Suzanne discusses what it means for a company to be &#x27;AI-native&#x27;, how the combination of AI and Real World Data is transforming clinical development, and how AI is enabling companies to get treatments to patients faster.<br>You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

How AI has revolutionised clinical development

The Drug Discovery World Podcast

# Full Transcript

**Podcast:** The Drug Discovery World Podcast

## Participants

- **Bruno Quinney** (DDW)
- **Suzanne Caruso** (Norstella)
- **Suzanne Caruso** (Norstella)

## Transcript

Hello and welcome to the DDW Podcast, a podcast covering topics around drug discovery and development, pharma and biotech. I'm Bruno Quinney, thanks for joining me for today's episode. Today I'm in conversation with Suzanne Caruso, President of Strategic Intelligence and Clinical and Regulatory at Norstellar.

Norstellar supports drug developers who are looking to take their treatments from pipeline to patients, finding solutions to complexities in the drug development timeline. One of these solutions is AI. It's no understatement to say that AI is dominating all our conversations, and drug development is no different.

AI is largely being implemented to augment clinical trials and increase R&D efficiency. But why has it suddenly become so crucial? I spoke to Suzanne about what it means for a company to be AI native, how the combination of AI and real world data is transforming clinical development,

and how AI is enabling companies to get treatments to patients faster. This is the DDW Podcast. Well, Suzanne, thank you very much for joining us on the DDW Podcast. Could you start, please, by introducing yourself and talk to us about what your role at Norstellar entails?

Nice to see you, and I'm Suzanne Caruso. I'm the General Manager of Clinical, Regulatory and Strategic Intelligence at Norstellar. And what that really means day to day is I lead a business that really provides data and intelligence and insights to pharmaceutical companies, CROs, and financial services companies. So from your perspective, what does it actually mean for a company to be AI native? I mean, there's so many different definitions these days. But when a company really reaches being AI native,

that means that a lot of the work and a lot of the products that they're putting out and a lot of the work that they're doing are actually being run by agents and supervised by the SMEs, who have really become the subject matter experts in whatever kind of experience that you are looking for those agents to do and that work to do on your behalf. So it really is a change from kind of the legacy way of working to trusting that, you know, agents are going to be able to do a lot of the work on your behalf

to a certain level of quality and you kind of have to oversee that orchestration. Do you ever find there's almost a shift in terms of responsibility? Because I suppose for a long time, people have been used to doing these roles themselves, haven't they? And suddenly we now have the technology and the capability to get these agents to do those tasks. Absolutely. It's also super cool and super exciting because, you know, it takes a lot of the things that you, as someone who's worked in the industry for a little bit of time,

were more administrative tasks kind of off of your plate. And it gives you...

How AI has revolutionised clinical development

Transcript

Built for investment professionals

Every day you wait, your competitors are finding
edge in conversations you're not hearing.

How AI has revolutionised clinical development

Transcript

Built for investment professionals

Every day you wait, your competitors are findingedge in conversations you're not hearing.

Every day you wait, your competitors are finding
edge in conversations you're not hearing.